The apelin-APJ signaling pathway has emerged as an important novel mediator of cardiovascular control and blood pressure homeostasis. Genetic variation in apelin and its receptors likely contributes to essential hypertension, in addition to a range of traditional risk factors. Thus, a study will be conducted on Syrian patients with hypertension and coronary artery disease to investigate some of the single polymorphisms in the apelin gene and its receptor that may be responsible for the development of these diseases, and to link the levels of this peptide and its receptor in the blood with these polymorphisms and the percentage of these diseases (as shown by many Modern Global Reference Studies).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Blood apelin concentrations
Timeframe: Collecting blood samples before angiography
Blood apelin receptor (APJ) concentrations
Timeframe: Collecting blood samples before angiography
The allelic and genotypic frequencies of the -1860T>C single polymorphism nucleotides of the apelin genes
Timeframe: Collecting blood samples before angiography
The allelic and genotypic frequencies of the G212A single polymorphism nucleotides of the apelin receptor genes
Timeframe: Collecting blood samples before angiography